India’s hip implant market is growing rapidly, fueled by a surge in osteoarthritis cases, an aging population, and rising adoption of modern orthopedic technologies. The country accounted for about 8{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} of the Asia-Pacific hip replacement market in 2025, according to GlobalData, with projections showing continued expansion through 2036. A compound annual growth rate (CAGR) of around 10{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481} is expected for the primary hip replacement devices segment, reflecting increased demand for solutions to degenerative joint disorders.
Prerna Gupta, a medical devices analyst at GlobalData, highlighted that the growing burden of degenerative joint diseases and greater patient awareness about mobility restoration are key drivers. She noted that advancements in implant materials, robotic-assisted surgery, and expanding orthopedic infrastructure are also playing a role. “These factors are creating a favorable environment for market growth,” she said, adding that urbanization and healthcare access improvements are contributing to the trend.
Related: Flu Vaccine Requirement Dropped: A Shot in the Dark for US Military Readiness
India’s aging population is a major catalyst. With life expectancy rising and joint-related conditions becoming more common, the need for hip replacements is increasing. Rural areas, however, still face challenges in accessing advanced treatments, though infrastructure investments are gradually closing this gap. “Affordability remains a hurdle, but innovations are expected to boost confidence among surgeons and patients alike,” she said.
Stryker, a global medical device manufacturer, has entered the Indian market with the Trident II Acetabular System, launched in April 2026. The system uses Tritanium In-Growth Technology and PureFix HA coating to enhance implant stability and longevity. It also integrates with Mako SmartRobotics, offering surgeons greater precision during total hip arthroplasty procedures. The modular dual mobility design aims to reduce dislocation risks, a common concern in joint replacements.
Related: Revolutionary Breakthrough in Pancreatic Cancer Treatment?
Such technological advances are reshaping surgical practices. The system’s compatibility with robotic-assisted techniques may improve outcomes, though widespread adoption will depend on training and cost considerations. “Modern implants and robotics are making complex procedures more accessible, but rural regions still lag in resources,” she noted. She emphasized that while urban centers are adopting these tools, equitable access remains a work in progress.
Despite progress, affordability barriers persist. Many patients in non-urban areas rely on public healthcare systems, which often lack the resources for advanced procedures. Private sector expansion and insurance coverage are slowly addressing this, but disparities remain. “Innovations like Stryker’s system are promising, but their impact will take time to materialize,” she said, pointing to the need for policy support and investment in rural healthcare.
Related: Revolutionary Gene Therapy for Deafness Shows Promising Results: Boosting Hope for Treatment
The market’s growth trajectory suggests a long-term shift. As awareness of hip replacement benefits spreads and technology becomes more integrated, demand is likely to outpace current supply. However, balancing cost, accessibility, and quality will be critical. For now, the sector remains a mix of opportunity and unmet needs, with India’s hip implant market poised to expand but requiring sustained effort to address systemic challenges.